Sebi has introduced a phased hike in net-worth and liquid capital norms for merchant bankers starting January 2026, alongside ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIR™ ...

Two Sarepta Therapeutics drugs for treating different genetic subsets of patients with Duchenne muscular dystrophy failed the confirmatory study required of their accelerated FDA approvals. Sarepta ...

Edesa Biotech has shared data from its truncated phase 3 respiratory failure trial, linking the anti-TLR4 antibody to improvements in survival and recovery. The trial enrolled about 100 people who ...

NEW YORK – A gene therapy for heart failure being advanced by Bayer's AskBio subsidiary has shown a promising safety profile and early signs of efficacy in a small first-in-human Phase I trial, ...

1 State Key Laboratory of Water Resource Protection and Utilization in Coal Mining, Beijing, China 2 School of Civil Engineering, Qingdao University of Technology, Qingdao, Shandong, China Exploring ...

Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids 1,2 Patients treated ...

East Hanover, August 12, 2025 – Novartis today announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag in patients with primary immune ...